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Background
NO-sensitive guanylyl cyclase (NO-GC) is the most
important effector protein for nitric oxide (NO) and is
involved in various physiological processes. Binding of
NO stimulates NO-GC up to 200-fold and thereby
increases cGMP synthesis. NO is generated by different
NO synthases (NOS). In the vasculature, endothelial
NOS (eNOS) is involved in the regulation of blood pres-
sure by relaxation of vascular smooth muscle. eNOS is
known to be stimulated by shear stress. In addition, NO
synthesis is stimulated by vascular endothelial growth
factor (VEGF) which acts as one of the most potent sti-
mulators of angiogenesis.
Until now the exact signalling pathway of VEGF-
induced NO has not been elucidated. S-nitrosylation of
p r o t e i nt h i o l sa sw e l la ss t i m u l a t i o no fN O - G Cw i t h
subsequent cGMP increases may underlie the angiogenic
effect of VEGF.
Method
In order to investigate the involvement of the NO/cGMP
cascade in VEGF-mediated angiogenesis we generated an
endothelial-specific NO-GC knock-out mouse (EC-
GCKO) using the Tie2-Cre line.
Results
Preliminary macroscopic analysis revealed that EC-
GCKO mice are indistinguishable from WT animals and
do not show any of the gross phenotypes of the total
GCKO mice. Several in vitro and in vivo techniques are
being used such as primary endothelial cell culture, aor-
tic ring assay and matrigel plug analysis.
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